Biosimilars for the Treatment of Retinal Diseases

被引：3
|
作者：
Hariprasad, Seenu M. [1 ]
Narayanan, Raja [2 ]
Sheth, Jay [3 ]
机构：
[1] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,Room S-439, Chicago, IL 60637 USA
[2] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Serv, Kallam Anji Reddy Campus,LV Prasad Marg,Opp PVR, Hyderabad 500034, Telangana, India
[3] Surya Eye Inst & Res Ctr, Dept Vitreoretinal Serv, Aroto House,104,Purushottam Kheraj Rd, Mumbai 400080, Maharashtra, India
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2021年 / 52卷 / 05期
关键词：
LESSONS;
D O I：
10.3928/23258160-20210429-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：242 / 246
页数：5
相关论文
共 50 条
  • [41] Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey)
    Sharma, Ashish
    Holz, Frank G.
    Regillo, Carl D.
    Freund, K. Bailey
    Sarraf, David
    Khanani, Arshad M.
    Baumal, Caroline
    Holekamp, Nancy
    Tadayoni, Ramin
    Kumar, Nilesh
    Parachuri, Nikulaa
    Kuppermann, Baruch D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 851 - 859
  • [42] Pharmacology and metabolism of infliximab biosimilars - A new treatment option in inflammatory bowel diseases
    Wlodarczyk, Marcin
    Fichna, Jakub
    Sobolewska-Wlodarczyk, Aleksandra
    PHARMACOLOGICAL REPORTS, 2016, 68 (04) : 797 - 801
  • [43] Pharmacology and metabolism of infliximab biosimilars — A new treatment option in inflammatory bowel diseases
    Marcin Włodarczyk
    Jakub Fichna
    Aleksandra Sobolewska-Włodarczyk
    Pharmacological Reports, 2016, 68 : 797 - 801
  • [44] Obstacles to the Adoption of Biosimilars for Chronic Diseases
    Hakim, Aaron
    Ross, Joseph S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (21): : 2163 - 2164
  • [45] Overview of Biosimilars in Inflammatory Bowel Diseases
    Feagins, Linda A.
    Gold, Stephanie
    Steinlauf, Adam F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (02): : 229 - 232
  • [46] Biosimilars in the therapy of inflammatory bowel diseases
    Hlavaty, Tibor
    Letkovsky, Juraj
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (06) : 581 - 587
  • [47] The Experience with Biosimilars of Infliximab in Rheumatic Diseases
    Azevedo, Valderilio Feijo
    Kos, Igor Age
    Ariello, Leonardo
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (44) : 6752 - 6758
  • [48] Optogenetics as a possible treatment for degenerative retinal diseases
    Mutter, Marion
    Benkner, Boris
    Muench, Thomas A.
    MEDIZINISCHE GENETIK, 2017, 29 (02): : 239 - 247
  • [49] Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases
    Zhang, Chun-Xia
    Lou, Yan
    Chi, Jing
    Bao, Xiao-Li
    Fan, Bin
    Li, Guang-Yu
    BIOMOLECULES, 2022, 12 (12)
  • [50] Targeting the photoreceptor cilium for the treatment of retinal diseases
    Jie Ran
    Jun Zhou
    Acta Pharmacologica Sinica, 2020, 41 : 1410 - 1415
12345